Truist Financial Corp Trims Stock Holdings in Danaher Corporation $DHR

Key Points

• Truist Financial trimmed its Danaher stake by 4.0%, selling 13,117 shares and ending the quarter with 313,476 shares valued at about $71.76 million, while institutions own roughly 79.05% of the stock.
• Quarterly results: Danaher beat EPS estimates ($2.06 vs. $1.94) but slightly missed revenue expectations ($5.95B vs. $6.0B), and raised its quarterly dividend to $0.40 from $0.32 (annualized $1.60, yield ~0.9%).
• Analyst sentiment and valuation: The stock carries a consensus "Moderate Buy" with a $240.70 price target, yet trades near its 52‑week low (~$174) with a market cap of about $123.4B and a P/E of ~33.7.

Truist Financial Corp trimmed its position in Danaher Corporation (NYSE:DHR - Free Report) by 4.0% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 313,476 shares of the conglomerate's stock after selling 13,117 shares during the period. Truist Financial Corp's holdings in Danaher were worth $71,761,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Tyche Wealth Partners LLC purchased a new stake in Danaher in the 3rd quarter valued at approximately $462,000. Bank Pictet & Cie Europe AG boosted its position in shares of Danaher by 25.4% in the 4th quarter. Bank Pictet & Cie Europe AG now owns 366,481 shares of the conglomerate's stock worth $83,895,000 after buying an additional 74,301 shares in the last quarter. Lockheed Martin Investment Management Co. boosted its position in shares of Danaher by 49.4% in the 3rd quarter. Lockheed Martin Investment Management Co. now owns 25,340 shares of the conglomerate's stock worth $5,024,000 after buying an additional 8,380 shares in the last quarter. Johnson Investment Counsel Inc. increased its stake in shares of Danaher by 2.9% during the 3rd quarter. Johnson Investment Counsel Inc. now owns 664,705 shares of the conglomerate's stock worth $131,784,000 after purchasing an additional 18,744 shares in the last quarter. Finally, Resona Asset Management Co. Ltd. lifted its position in shares of Danaher by 4.6% in the third quarter. Resona Asset Management Co. Ltd. now owns 513,288 shares of the conglomerate's stock valued at $100,071,000 after acquiring an additional 22,595 shares in the last quarter. 79.05% of the stock is owned by hedge funds and other institutional investors.

Danaher Stock Performance

Danaher stock opened at $174.29 on Tuesday. The stock has a market cap of $123.36 billion, a P/E ratio of 33.71, a price-to-earnings-growth ratio of 2.34 and a beta of 0.81. The company has a current ratio of 1.87, a quick ratio of 1.52 and a debt-to-equity ratio of 0.33. The stock has a 50 day moving average of $193.34 and a 200-day moving average of $213.25. Danaher Corporation has a 52 week low of $172.34 and a 52 week high of $242.80.

Danaher (NYSE:DHR - Get Free Report) last released its earnings results on Monday, April 20th. The conglomerate reported $2.06 EPS for the quarter, beating the consensus estimate of $1.94 by $0.12. The company had revenue of $5.95 billion during the quarter, compared to analysts' expectations of $6 billion. Danaher had a return on equity of 10.91% and a net margin of 14.89%.The business's revenue was up 3.7% on a year-over-year basis. During the same period in the prior year, the business posted $1.88 EPS. On average, analysts expect that Danaher Corporation will post 8.43 EPS for the current fiscal year.

Danaher Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, April 24th. Stockholders of record on Friday, March 27th were given a $0.40 dividend. This represents a $1.60 annualized dividend and a dividend yield of 0.9%. The ex-dividend date of this dividend was Friday, March 27th. This is an increase from Danaher's previous quarterly dividend of $0.32. Danaher's payout ratio is presently 30.95%.

Insiders Place Their Bets

In related news, EVP Gregory M. Milosevich sold 1,320 shares of the business's stock in a transaction dated Thursday, February 19th. The stock was sold at an average price of $208.01, for a total value of $274,573.20. Following the completion of the sale, the executive vice president directly owned 5,099 shares of the company's stock, valued at $1,060,642.99. The trade was a 20.56% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. 10.80% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

A number of equities research analysts have recently commented on DHR shares. Guggenheim lowered their price target on shares of Danaher from $275.00 to $235.00 and set a "buy" rating for the company in a report on Wednesday, April 22nd. Leerink Partners increased their price target on shares of Danaher from $260.00 to $270.00 and gave the stock an "outperform" rating in a research note on Friday, January 16th. KeyCorp restated an "overweight" rating on shares of Danaher in a report on Thursday, January 29th. Evercore upped their price target on shares of Danaher from $225.00 to $232.00 and gave the stock an "outperform" rating in a research report on Tuesday, April 21st. Finally, Rothschild & Co Redburn set a $205.00 target price on shares of Danaher in a research note on Friday, April 17th. Eighteen research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company's stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $240.70.

Danaher Company Profile

Danaher Corporation NYSE: DHR is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher's portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.